Hippocampal volume and the AKT signaling system in first-episode schizophrenia.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Psychiatric Research

• Publication date

  2012-03-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.jpsychires.2011.12.005PMID 22209534
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hippocampal Volume Reduction in First-Episode and Chronic Schizophrenia

  2012cited by this paper
• A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health.

  2012cited by this paper
• Akt1 deficiency in schizophrenia and impairment of hippocampal plasticity and function

  2012cited by this paper
• Neuregulin-1 Signals from the Periphery Regulate AMPA Receptor Sensitivity and Expression in GABAergic Interneurons in Developing Neocortex

  2011cited by this paper
• New from NPG: Genome-wide association study identifies five new schizophrenia loci

  2011cited by this paper
• Modelling schizophrenia using human induced pluripotent stem cells

  2011cited by this paper
• Modelling schizophrenia using human induced pluripotent stem cells

  2011cited by this paper
• Neuregulin 1 Promotes Excitatory Synapse Development and Function in GABAergic Interneurons

  2011cited by this paper
• Developmental pathology, dopamine, stress and schizophrenia

  2011cited by this paper
• Epistatic interactions of AKT1 on human medial temporal lobe biology and pharmacogenetic implications

  2011cited by this paper
• Association of serum BDNF levels with hippocampal volumes in first psychotic episode drug-naive schizophrenic patients.

  2011cited by this paper
• The relationship among neuregulin 1-stimulated phosphorylation of AKT, psychosis proneness, and habituation of arousal in nonclinical individuals.

  2011cited by this paper
• Subchronic Peripheral Neuregulin-1 Increases Ventral Hippocampal Neurogenesis and Induces Antidepressant-Like Effects

  2011cited by this paper
• Biodistribution and brain permeability of the extracellular domain of neuregulin-1-β1.

  2011cited by this paper
• Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis.

  2011cited by this paper
• Molecules, signaling, and schizophrenia.

  2010cited by this paper
• Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling

  2010cited by this paper
• Suppression of the P50 evoked response and neuregulin 1-induced AKT phosphorylation in first-episode schizophrenia.

  2010influential reference
• Higher cortisol levels are associated with smaller left hippocampal volume in first-episode psychosis.

  2010cited by this paper
• Hippocampal subdivision and amygdalar volumes in patients in an at-risk mental state for schizophrenia.

  2010cited by this paper
• Hippocampal and caudate volume reductions in antipsychotic-naive first-episode schizophrenia.

  2010cited by this paper
• The hippocampal formation in schizophrenia.

  2010cited by this paper
• Hippocampus abnormalities in at risk mental states for psychosis? A cross-sectional high resolution region of interest magnetic resonance imaging study.

  2010cited by this paper
• The neuregulin signaling pathway and schizophrenia: from genes to synapses and neural circuits.

  2010cited by this paper
• Hippocampal pathology in schizophrenia.

  2010cited by this paper
• Studies on the hippocampal formation: From basic development to clinical applications: Studies on schizophrenia.

  2010cited by this paper
• Epistatic and Functional Interactions of Catechol-O-Methyltransferase (COMT) and AKT1 on Neuregulin1-ErbB Signaling in Cell Models

  2010cited by this paper
• CACNA1C risk allele for psychotic disorders is related to the activation of the AKT-pathway.

  2010cited by this paper
• Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action.

  2010cited by this paper
• Signaling pathways in schizophrenia: emerging targets and therapeutic strategies.

  2010cited by this paper
• The MAP kinase signaling cascades: a system of hundreds of components regulates a diverse array of physiological functions.

  2010cited by this paper
• Neuregulin 1-induced AKT phosphorylation in monozygotic twins discordant for schizophrenia.

  2010cited by this paper
• Neuregulin 1-stimulated phosphorylation of AKT in psychotic disorders and its relationship with neurocognitive functions.

  2009cited by this paper
• The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis.

  2008influential reference
• Neuregulin-1 haplotype HAP(ICE) is associated with lower hippocampal volumes in schizophrenic patients and in non-affected family members.

  2008cited by this paper
• Identification of loci associated with schizophrenia by genome-wide association and follow-up

  2008cited by this paper
• Impact of neuregulin-1 on the pathophysiology of schizophrenia in human post-mortem studies

  2008cited by this paper
• Neuregulin 1 in neural development, synaptic plasticity and schizophrenia

  2008cited by this paper
• Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia.

  2008cited by this paper
• Neuroplasticity of Neocortical Circuits in Schizophrenia

  2008cited by this paper
• Neuregulin1-induced cell migration is impaired in schizophrenia: association with neuregulin1 and catechol-o-methyltransferase gene polymorphisms

  2007influential reference
• New genes associated with schizophrenia in neurite formation: a review of cell culture experiments

  2007cited by this paper
• The role of the phosphatidylinositide 3-kinase-protein kinase B pathway in schizophrenia.

  2006cited by this paper
• Brain volume in first-episode schizophrenia

  2006influential reference
• Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies.

  2006cited by this paper
• Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology.

  2006cited by this paper
• MR-based in vivo hippocampal volumetrics: 2. Findings in neuropsychiatric disorders

  2005cited by this paper
• Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia

  2005cited by this paper
• Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies.

  2005cited by this paper
• A hybrid approach to the skull stripping problem in MRI

  2004cited by this paper
• Sequence-independent segmentation of magnetic resonance images.

  2004cited by this paper
• Meta-analysis of regional brain volumes in schizophrenia.

  2000cited by this paper
• Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study.

  1998cited by this paper
• The positive and negative syndrome scale (PANSS) for schizophrenia.

  1987cited by this paper
• Neuregulin 1 and Schizophrenia: Genetics, Gene Expression, and Neurobiology Neurobiology of Neuregulin 1

  year unknowncited by this paper

• Network toxicology and molecular docking reveal key mechanisms of domoic acid neurotoxicity with bio-layer interferometry validation.

  2025cites this paper
• Hippocampal perfusion abnormalities and treatment effects in acute phase of first-episode schizophrenia.

  2025cites this paper
• Trim46 knockout impaired neuronal architecture and caused hypoactive behavior in rats

  2024cites this paper
• A randomized controlled trial of Vitamin D supplementation in Iranian patients with schizophrenia: Effects on serum levels of glycogen synthase kinase‐3β and symptom severity

  2023cites this paper
• Treatment of Cancer with Antipsychotic Medications: Pushing the Boundaries of Schizophrenia and Cancer.

  2022cites this paper
• Multidimensional predictors of negative symptoms in antipsychotic-naive first-episode psychosis

  2022cites this paper
• Corticosterone antagonist or TrkB agonist attenuates schizophrenia-like behavior in a mouse model combining Bdnf-e6 deficiency and developmental stress

  2022cites this paper
• Functional variants fine‐mapping and gene function characterization provide insights into the role of ZNF323 in schizophrenia pathogenesis

  2021cites this paper
• Behavioral Deficits in Mice with Postnatal Disruption of Ndel1 in Forebrain Excitatory Neurons: Implications for Epilepsy and Neuropsychiatric Disorders

  2021cites this paper
• Investigation of DRD2 and HTR2A mRNA Expression in Two Therapeutic States of Antipsychotic Polypharmacy and Aripiprazole Monotherapy in the Peripheral Blood of Patients With Schizophrenia

  2020cites this paper
• Putative Mechanisms of Action and Clinical Use of Lithium in Children and Adolescents: A Critical Review

  2017cites this paper
• Uniting the neurodevelopmental and immunological hypotheses: Neuregulin 1 receptor ErbB and Toll-like receptor activation in first-episode schizophrenia

  2017cites this paper
• Schizophrenia: neuroinflammation, neurodegeneration or neurodevelopment? A genetic overview

  2017cites this paper
• Cancer Immune Equilibrium and Schizophrenia Have Similar Interferon-γ, Tumor Necrosis Factor-α, and Interleukin Expression: A Tumor Model of Schizophrenia.

  2016cites this paper
• Akting up in the GABA hypothesis of schizophrenia: Akt1 deficiency modulates GABAergic functions and hippocampus-dependent functions

  2016cites this paper
• The mRNA expression of DRD2, PI3KCB, and AKT1 in the blood of acute schizophrenia patients.

  2016cites this paper
• Dimensions of GSK3 Monoamine-Related Intracellular Signaling in Schizophrenia

  2016cites this paper
• Involvement of the Wnt Signal Pathway in Hippocampal Plasticity

  2014cites this paper
• The emerging role of dopamine–glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: Implications for treatment

  2014cites this paper
• Neurodevelopment in Schizophrenia: The Role of the Wnt Pathways

  2013cites this paper
• Glycogen synthase kinase-3beta affects size of dentate gyrus and species-typical behavioral tasks in transgenic and knockout mice.

  2013cites this paper
• Perceptual and cognitive effects of antipsychotics in first-episode schizophrenia: the potential impact of GABA concentration in the visual cortex.

  2013cites this paper
• BDNF-TrkB signaling and neuroprotection in schizophrenia.

  2013cites this paper
• Electrophysiological and behavioral responses to ketamine in mice with reduced Akt1 expression

  2013cites this paper
• Current World

  2013cites this paper
• The possible role of the Akt signaling pathway in schizophrenia.

  2012cites this paper